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We have previously defined ie3 as a coding region located downstream of the iel gene which gives rise to a
2.75-kb immediate-early (IE) transcript. Here we describe the structural organization of the ie3 gene, the
amino acid sequence of the gene product, and some of the functional properties of the protein. The 2.75-kb ie3
mRNA is generated by splicing and is composed of four exons. The first three exons, of 300, 111, and 191
nucleotides (nt), are shared with the iel mRNA and are spliced to exon 5, which is located downstream of the
fourth exon used by the iel mRNA. Exon 5 starts 28 nt downstream of the 3' end of the iel mRNA and has a
length of 1,701 nt. The IE3 protein contains 611 amino acids, the first 99 of which are shared with the iel
product pp89. The IE3 protein expressed at IE times has a relative mobility of 88 kDa in gels, and a mobility
shift to 90 kDa during the early phase is indicative of posttranslational modification. Sequence comparison
reveals significant homology of the exon 5-encoded amino acid sequence with the respective sequence of UL 122,
a component of the IE1-IE2 complex of human cytomegalovirus (HCMV). This homology is also apparent at
the functional level. The IE3 protein is a strong transcriptional activator of the murine cytomegalovirus
(MCMV) el promoter and shows an autoregulatory function by repression of the MCMV iel/ie3 promoter. The
high degree of conservation between the MCMV ie3 and HCMV IE2 genes and their products with regard to
gene structure, amino acid sequence, and protein functions suggests that these genes play a comparable role in
the transcriptional control of the two cytomegaloviruses.
Murine cytomegalovirus (MCMV) is a member of the
highly diverse group of herpesviruses. As with other herpes-
viruses, the expression of MCMV genes occurs in a regu-
lated fashion (21). The immediate-early (IE) genes are the
first genes to be expressed after infection. Transcription of
IE genes does not require de novo protein synthesis. IE
proteins have regulatory functions that are required for the
coordinated expression of early and late genes.
The genomic region of MCMV, which is abundantly
transcribed at IE times, is located between map units 0.769
and 0.818 of the genome, and its structural organization is
similar to that of the IE regions of human and simian
cytomegaloviruses (HCMV and SCMV, respectively) (19,
22, 23, 45, 46). Transcription of the MCMV IE genes is under
the control of a large and complex enhancer which controls
promoters flanking this sequence on both sides (13). Three
IE genes have been identified within the MCMV IE region
(22, 23, 35). The most abundantly transcribed IE gene of
MCMV, iel, is, like the homologous genes of HCMV and
SCMV, composed of a first noncoding exon, two small
exons, and a large fourth exon (19, 22, 45). The abundantly
expressed IE protein encoded by the MCMV iel gene has a
molecular mass of 89 kDa (22, 24, 50). Like its counterparts
from HCMV and SCMV, it is a phosphorylated nuclear
protein with a high percentage of acidic residues (19, 24, 45).
Remarkably, however, there is very little homology between
the nucleic acid sequences and the amino acid sequences. A
unique feature of MCMV is the location of a second IE
transcription unit, ie2, on the other side of the enhancer
sequence (23, 35). The function of the 43-kDa IE2 protein is
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unknown (25, 35), and the ie2 gene seems to be nonessential
for growth of the virus in cell culture (32).
Downstream of the abundantly expressed IE gene is
another transcribed region which is referred to as IE2 in
HCMV and SCMV and ie3 in MCMV (18, 23, 38, 46). In
HCMV and SCMV, the major IE2 transcript is spliced
together from the first three exons of the IE1 gene and a fifth
exon in the IE2 region (18, 43, 46). This HCMV IE2
transcript is translated into a 579-amino-acid polypeptide
with an apparent molecular mass of 88 kDa (30, 43, 44).
The most thorough analysis of the regulatory functions of
the IE proteins has been performed with HCMV (18, 30, 37,
38, 44). Transient transfection experiments using chloram-
phenicol acetyltransferase (CAT) indicator plasmids with
various heterologous as well as homologous promoters re-
vealed that the HCMV IE2 protein is a strong activator of
early promoters. In addition, the HCMV IE2 protein re-
presses the major IE promoter of HCMV, suggesting an
autoregulative role for IE2 (6, 17, 28, 37). The HCMV IEl
protein seems to cooperate with the IE2 protein in the
regulation of some promoters (4), but IEl alone is not
sufficient for the activation of early promoters (30, 44).
We have suggested previously that the MCMV ie3 gene
may encode a regulatory protein with similarities to the
HCMV IE2 protein (23). In this communication, we report
on the structural analysis of the ie3 gene, the determination
of the ie3 open reading frame, and the identification of the
IE3 protein. Partial homology between the amino acid se-
quences of the MCMV IE3 and the HCMV IE2 proteins
suggests a correlation between protein structure and func-
tion. Functional assays using the MCMV early promoter el
(3) and the MCMV iellie3 promoter show that the MCMV
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IE3 protein has regulatory properties comparable to those of
the HCMV IE2 protein.
MATERIALS AND METHODS
Virus and cell culture. MCMV (mouse salivary gland virus
strain Smith; ATCC VR-194) was propagated on BALB/c
mouse embryonal fibroblasts (MEF) as described previously
(21). Recombinant vaccinia viruses were produced by fol-
lowing established procedures (29) and using the recombina-
tion vector pCS43 (1), vaccinia virus DNA of strain Copen-
hagen, and the temperature-sensitive mutant ts7 (14). For
recombination of the ie3 open reading frame into the vac-
cinia virus genome, the continuous ie3 coding sequence was
constructed. A 717-bp amplified DNA fragment (see Fig. 3C,
lane E3), which contained 133 nucleotides (nt) of exon 3
sequences fused to 584 nt of exon 5 sequences (see Fig. 1),
was cloned into the HincII site of pEMBL19. The resulting
plasmid was digested with BamHI and MscI, and a 420-bp
BglII-MscI fragment isolated from plasmid p62/3 (10) was
inserted. The 420-bp fragment contains 149 nt of the first
intron, an EcoRI site in front of the first ATG, exon 2, and
173 nt of exon 3. The insertion of the 420-bp fragment
restored the beginning of the ie3 open reading frame. To
provide the complete sequences of exon 5, the construct was
digested with XbaI and HindIII, and exon 5 sequences were
inserted as a 2.7-kbp XbaI-HindIII fragment comprising map
units 0.780 to 0.769. The continuous ie3 open reading frame
was then isolated as a 2.9-kbp EcoRI fragment and inserted
into the EcoRI site of the recombination vector pCS43.
Production of specific antisera. The expression vector
pATH11, which contains a part of the Escherichia coli TrpE
reading frame downstream of the inducible TrpE promoter
(12), was chosen to construct a plasmid encoding a TrpE-IE3
fusion protein. Plasmid pATH11 was digested with XbaI and
PstI, and the 870-bp XbaI-PstI fragment of the MCMV ie3
region (map units 0.780 to 0.776) was inserted. The expres-
sion plasmid pATH11-IE3 contains an open reading frame
encoding a polypeptide which consists of 334 amino acids of
the TrpE protein followed by 290 amino acids of the putative
IE3 protein. The production of the fusion protein was
induced in E. coli C600 with indolacrylic acid (10 pug/ml) in
the absence of tryptophan as described previously (40).
Bacteria were harvested 5 h later, and following suspension
in lysis buffer (0.8 mg of lysozyme per ml in 6.7% sucrose-80
mM EDTA-30 mM Tris [pH 8.0]) and sonication, the pro-
teins were isolated by successive extraction with 1 and 7 M
urea. The 66-kDa TrpE-IE3 fusion protein was mainly con-
tained in the 7 M urea fraction. The isolated protein was
dialyzed against 0.1 M ammonium carbamate. Rabbits were
injected subcutaneously with 50 pug of protein three times
with 14-day intervals and bled after 8 weeks. Production of
the monoclonal antibody (MAb) 6/20/1 and the antipeptide
serum bS/1 has been described previously (10, 24).
Plasmids for the analysis of the regulatory functions of the
IE proteins. Recombinant plasmids were constructed ac-
cording to established procedures (31). For the construction
of the indicator plasmid pElCAT, the plasmid pBB5.5 was
used. Plasmid pBB5.5 contains the sequences from map
units 0.698 to 0.721 of the MCMV genome as a 5.5-kbp PstI
fragment. This 5.5-kbp PstI fragment includes 2.6 kbp of the
el promoter and 2.9 kbp of the el coding sequences (3).
pBB5.5 was digested with NcoI and HindIII, thereby remov-
ing all coding sequences of the el gene. The NcoI site is
located 118 nt downstream of the 5' cap site of the el gene
directly at the translation start codon of the el open reading
frame. The ATG at the NcoI site was removed by nuclease
Si digestion, and a HindIII linker was added. For isolation
of the CAT gene, plasmid pSV2CAT (16) was linearized with
BamHI, the BamHI site was filled in by Klenow enzyme,
and a HindlIl linker was added. The CAT gene was then
isolated by digestion with HindIII as a 1.6-kbp HindlIl
fragment and inserted into the modified pBB5.5 plasmid 118
nt downstream of the 5' cap site of the el gene.
For the construction of the indicator plasmid pIElCAT,
the MCMV enhancer sequences, the iellie3 promoter, and
the first 49 nt of exon 1 of the iel gene were isolated from the
plasmid pAMB33 (23). pAMB33 contains a 2.25-kbp PstI
fragment from map units 0.806 to 0.796. pAMB33 was
digested with SmaI in the polylinker sequences, and a
HindlIl linker was added. Then, a 2.25-kbp HindlIl frag-
ment was isolated and ligated into the Hindlll site of
pSVOCAT (16). In the resulting plasmid, pIElCAT, the CAT
gene is fused to the leader sequence of the iel gene at
position +49.
To construct a plasmid selectively encoding the IE3 pro-
tein, the plasmid pIE111 (23) was cut with MscI and XbaI,
thereby removing all sequences downstream of the MscI site
in the third exon of the iel gene. A 552-bp MscI-XbaI
fragment was isolated from the 717-bp amplification product
(see Fig. 3C, lane E3). This fragment, which contained 18 nt
from the end of exon 3 linked to the first 534 nt of exon 5,
was fused at the MscI site in exon 3. The remaining part of
the ie3 region was added at the XbaI site corresponding to
map unit 0.780 as a 2.7-kbp XbaI-HindIII fragment (map
units 0.780 to 0.769).
Synthetic oligonucleotides. Synthetic oligonucleotides for
polymerase chain reactions and sequencing were synthe-
sized by an Applied Biosystems 381A DNA synthesizer and
purified by urea-polyacrylamide gel electrophoresis. The 5'-
to 3'-sequences of the oligonucleotides are as follows: El,
CTGCCCAAGAAAGAGCGACCTTCCCC; E2, CCAGTT
GCAACATGATCATGATCGC; E3, GACCTGACTCTGG
AGGACATGTTGGG; E5, GGTACCTGAACGCCACCAT
CCTTTC; IE3.1, GAAGTCTGGGGTGTTTGGTCTTCTG
ATTG; IE3.END, TCTGCATTTGAGTCAGG; (dT)17-R1-
RO, AAGGATCCGTCGACATCGATAATACGACTCACT
ATAGGGATTTTTTTTTTTTTTTTT; and RO, AAGGATC
CGTCGACATC (see also Fig. 3A).
Isolation of IE RNA. MEF were infected for 6 h with
MCMV at a multiplicity of infection of 20 PFU per cell in the
presence of cycloheximide (50 pug/ml) by using the technique
of centrifugal enhancement of infectivity at 800 x g for 30
min. Total cell RNA was prepared by following published
procedures (7).
Preparation of cDNA and polymerase chain reaction. A
10-pul volume containing 5 pug of IE RNA and 20 pM 3'
primer in H20 were heated at 65°C for 5 min and then
quenched on ice. Reverse transcription of the RNA was
performed in a 20-pd reaction mixture containing 100 mM
Tris (pH 8.3), 150 mM KCl, 10 mM MgCl2, 10 mM dithio-
threitol, 400 ,uM deoxynucleoside triphosphates (dNTPs), S
U of human placental RNase inhibitor, and 10 U of murine
reverse transcriptase (Pharmacia, Uppsala, Sweden) for 1 h
at 42°C. The synthesized cDNA was subjected to amplifica-
tion with 2.5 U of Taq polymerase (Perkin Elmer Cetus,
Norwalk, Conn.) in a 100-pul reaction mixture which con-
tained 1 puM 3' and 5' primers, 200 puM dNTPs, 10 mM Tris
(pH 8.0), 50 mM KCl, and 1.5 mM MgCl2. Thirty-five cycles
were carried out in a thermocycler (Biomed, Obertheres,
Germany) under the following conditions: denaturation at
94°C for 2 min, primer annealing at 55°C for 4 min, and
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elongation at 72°C for 4 to 7 min depending on the expected
length of the amplified product. The determination of the 3'
end of the ie3 mRNA was done by the protocol of Frohman
et al. (15).
DNA sequencing. DNA sequence analysis was carried out
by using the method of Maxam and Gilbert (33) and a
modified version of the enzymatic chain termination method
(48). Direct sequencing of amplified DNA fragments was
performed as follows. The DNA fragment was isolated from
agarose gels by using the standard protocol for Geneclean
DNA purification (Geneclean; BIO 101, Inc., La Jolla,
Calif.). For the annealing reaction, the isolated DNA (500
ng) was suspended in a reaction mixture containing 1.5 pM
primer, 100 mM Tris (pH 8.3), 150 mM KCI, 10 mM MgCl2,
and 10 mM dithiothreitol, and was then incubated for 10 min
at 100°C and for 10 min at room temperature. Labeling and
extension reactions with polymerase T7 and [35S]dATP
(Amersham, Braunschweig, Germany) were performed as
recommended by the supplier of the sequencing kit (Phar-
macia).
Western blotting (immunoblotting). MEF were infected
with MCMV at 20 PFU per cell by using the technique of
centrifugal enhancement of infectivity at 800 x g for 30 min.
For selective expression of IE proteins, the cells were
incubated from 0 to 3 h postinfection (p.i.) in the presence of
cycloheximide (50 ,ug/ml), which was replaced from 3 to 7 h
p.i. with actinomycin D (5 jig/ml). Infections with vaccinia
viruses were performed at a multiplicity of infection of 20.
Samples (106 cells) were lysed in protein sample buffer (3.4%
sodium dodecyl sulfate [SDS], 20 mM dithiothreitol, 70 mM
Tris [pH 6.8]), sonicated three times for 10 s, and boiled for
5 min. The polypeptides of the cell lysates were separated by
7.5 to 15% gradient SDS-polyacrylamide gel electrophoresis
and transferred electrophoretically to nitrocellulose filters.
Incubation of the filters with antisera and immunostaining
were performed as described previously (3, 24).
DNA transfection and CAT assay. All plasmids were puri-
fied twice by cesium chloride gradients. Quantification of
plasmids was performed spectrophotometrically. Quality of
plasmid DNAs was examined by restriction enzyme diges-
tion and gel electrophoresis. For transient gene expression
assays, second-passage MEF were seeded into 60-mm-
diameter plastic dishes (Greiner, Nuirtingen, Germany) at 16
h prior to transfection. Effector and indicator plasmids (1
pmol) were transfected in duplicate by the calcium phos-
phate technique. All transfection experiments were repeated
at least three times with different plasmid preparations. The
experiments discussed here were carried out without carrier
DNA, since the addition of carrier DNA to equalize the
amount of DNA used for transfection had no effect on the
resulting enzyme activity. Cells were harvested 40 h after
transfection, and cell extracts were prepared according to
the procedure of Gorman et al. (16). The 1-h standard assays
and thin-layer chromatography were performed as described
previously (25). Radioactive chloramphenicol was visualized
by overnight exposure to Kodak X-Omat S films. For
quantification, the chloramphenicol spots were excised from
the silica plates and counted in a liquid scintillation counter.
Nucleotide sequence accession number. The GenBank ac-
cession number for the nucleotide sequence reported in this
article is M77846.
RESULTS
Nucleotide sequence and structural analysis of the ie3 gene.
Our previous experiments have shown that two 2.75-kb
mRNAs originate from the abundantly transcribed IE region
of MCMV (Fig. 1). As DNA probes from the iel and ie3
region hybridize with a 2.75-kb mRNA as well as with a
5.1-kb RNA, it was concluded that the two 2.75-kb mRNAs
probably represent alternative splice products of a primary
5.1-kb transcript. Hybrid selection and in vitro translation
experiments suggested that both transcripts originate at least
partially from the same regions and that they are spliced
from common exons (23). Furthermore, we have observed
that sequences downstream of the iel gene are transcribed at
IE times and that the endpoint of an mRNA with moderate
abundance is located between map units 0.776 (PstI) and
0.773 (XhoI) (Fig. 1) (23). From these previous findings and
by analogy to the structure of the HCMV IE region, it was
predicted that the MCMV ie3 gene would share its first three
exons with the MCMV iel gene and that alternative splicing
from the third exon to a fifth exon downstream of exon 4 of
the MCMV iel gene would occur.
To identify the putative open reading frame of exon 5, the
nucleic acid sequence of the region downstream of the iel
gene was analyzed. Figure 2 shows the nucleotide sequence
from the polyadenylation signal of the iel mRNA to 50 nt
downstream of the putative polyadenylation signal of the ie3
transcript. The restriction enzyme sites AvaI (map unit
0.783), XbaI (map unit 0.780), and PstI (map unit 0.776) are
indicated for orientation. An open reading frame encoding
528 amino acids was identified within this region.
To study whether this coding sequence is spliced in total
or in part to exon sequences of the iel gene, reverse
transcription of the ie3 mRNA and amplification of the
resulting ie3 cDNA were performed. Primers El, E2, and E3
were chosen from the upper strands of exon 1, exon 2, and
exon 3 of the iel gene, respectively (Fig. 3A and reference
22). Primer E5 corresponds to positions 560 to 584 in the
lower strand shown in Fig. 2 and is therefore located far
downstream of the expected 5' end of exon 5.
The 3' primer E5 was hybridized to IE RNA and elongated
with reverse transcriptase. The synthesized cDNA was
amplified by using primer pairs El-E5, E2-E5, and E3-E5.
The amplification resulted in DNA fragments- of 1,100, 850,
and 700 bp, thus confirming the prediction that sequences of
the ie3 region are spliced to the third exon of the iel gene
(Fig. 3C). Some smaller fragments of an amount that varied
between experiments were interpreted as single-stranded
templates because of an unbalanced amount of the two
primers and were not further analyzed.
To locate the 5' end of exon 5 and to confirm that exon
sequences of the iel gene are included in the ie3 transcript,
sequence analysis of the amplified fragments was performed
with primers E2, E3, and IE3. 1. Primer IE3.1 corresponds to
positions 79 to 107 from the expected start of exon 5 in the
lower strand shown in Fig. 2. The 700- and 850-bp DNA
fragments were eluted from the agarose gel and sequenced
directly. The sequence analysis located the 5' end of the fifth
exon 538 nt upstream of the XbaI site (map unit 0.780). A
splice accepter consensus sequence, CTTTATGGTTCAC
AG, was identified upstream of the 5' end of exon 5
(positions -15 to -1 in Fig. 2). Therefore, the 5' end of exon
5 is located 54 and 28 nt downstream of the polyadenylation
signal and the 3' end of the 2.75-kb iel transcript, respec-
tively (22).
The sequence analysis of the amplified DNA fragments
confirmed that the ie3 transcript is composed of the first
three exons of the iel gene and exon 5 in the ie3 region. The
open reading frame of the ie3 transcript starts at the begin-
ning of exon 2, continues through the exon 3 sequences, and
VOL. 66, 1992
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FIG. 1. (Top) Physical tnap of the MCMV genome with Hindill cleavage sites and location of the transcription unit el. (Middle)
Organization of the abundantly transcribed IE region between map units 0.769 and 0.818. Abbreviations of restriction enzyme sites used for
ie3 gene characterization and cloning purposes: A, AvaI; B, BamHI; Bg, BgIII; X, EcoRI; H, Hindlll; Hp, HpaI; M, MscI; P, PstI; X, XbaI;
Xh, XhoI. The splicing patterns of the iel, ie2, and ie3 genes are drawn to scale. Coding sequences are shown as black bars. The hatched bar
represents the enhancer sequences. (Bottom) Effector plasmids used for analysis of the regulatory functions of the IE proteins. The dotted
line indicates deleted sequences.
uses a further 511 of the 528 codons of the open reading
frame in the ie3 region (Fig. 2). A polyadenylation consensus
sequence, AATAAA, is located 137 nt downstream of the
stop codon TGA (positions 1676 to 1682 in Fig. 2). The
sequence GCACTTGTGTCTTGT, 20 nt downstream of the
putative polyadenylation signal (positions 1703 to 1717 in
Fig. 2), shows homology to the typical 3' end consensus
sequences CAC/TTG and YGTGTTYY (2).
The 3' end of the ie3 transcript was determined by reverse
transcription of the ie3 mRNA and amplification of the
cDNA end according to the method of Frohman et al. (15).
In brief, the primer (dT)17-R1-R0 was annealed to IE RNA,
and reverse transcription was performed. Amplification of
the 3' end of the ie3 cDNA was achieved by utilizing the ie3
gene-specific primer IE3.END (Fig. 3A) and primer RO. A
350-bp fragment was identified after amplification and sub-
cloned into pUC19. Sequence analysis located the 3' end of
the ie3 mRNA to position 1701 (Fig. 2 and 3D). S1 analysis
with different 5' and 3' end-labeled probes of the ie3 region
confirmed the 5' and 3' ends of exon 5 we had determined
and revealed no indication for additional splicing within the
ie3 region (data not shown).
Thus, the ie3 mRNA contains four exons of 300, 111, 191,
and 1,701 nt comprising 2.3 kb (Fig. 3B). The sizes of the
introns are 825, 111, 191, and 1,856 nt. The observed size of
2.75 kb for the ie3 mRNA in Northern (RNA) blot analysis is
in accord with the calculated size if the increase in size of the
mRNA by polyadenylation is considered. Furthermore, the
calculated sizes of 2,305 nt for the iel transcript (22) and
2,303 nt for the ie3 transcript explain the comigration of the
iel and ie3 2.75-kb mRNAs in agarose gels seen previously
(23).
Homology of MCMV IE3 and HCMV IE2 amino acid
sequences. The amino acid sequence of the IE3 protein was
deduced from the nucleotide sequence of the ie3 mRNA
(Fig. 4). The predicted IE3 protein contains 611 amino acids
and has a calculated molecular mass of 68 kDa. As the iel
mRNA and the ie3 mRNA both use the information of exon
2 and 3, the first 99 amino acids at the amino-terminal ends
of pp89 and the IE3 protein are identical. Some interesting
regions within the unique amino acid sequence of the IE3
protein defined by exon 5 sequences were identified. Three
clusters with acidic residues, i.e., amino acids 166 to 177,
180 to 188, and 231 to 239, were observed, although the
overall content of acidic amino acids (92 residues) is bal-
anced by a similar number of basic residues (110 residues),
resulting in a calculated isoelectric point of 6.75. The se-
quence Lys-Lys-Ala-Lys-Lys-His-Lys between positions
141 and 147 shows similarity to the simian virus 40 large T
antigen nuclear location signal Lys-Lys-Lys-Arg-Lys (20).
Another series of basic amino acids, Arg-His-His-His-Lys-
Arg-Lys between positions 279 and 285, may represent a
second nuclear location signal. A cluster of five gliutamine
residues was found at positions 365 to 370 of the IE3 amino
acid sequence. Serine residues, often clustered, are frequent
(17%), especially in the middle of the IE3 amino acid
sequence. The serine clusters may represent phosphoryla-
tion sites. According to Chou and Fasman (8), the high
number of serine residues together with glycine and alanine
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ATGAGGACTT TATTMTCAG CAGCCTCABG AGGAGGArTA TCMGAGA6 CAGGAGCCCC AGGTGATCTC 280
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CCTGAA6ATC AASTCCTTCA 66CCCCCTAG CTCTG6TTCC AACTCCAACA AACACA CAGCMCTCTGGT666TCTACTAGTACTA CAAGAAGA CACMCAGC A6CCCCTA CAAGAAGCCT GTGATBMTA
6TGG1A6TGA TAA6ATCAGA ACATGGTAG ACAGACABC COGGCTAC GTGGCCCCCA ACGCCCACAA
SABTGCA6 GAAGATAAGT CCAGBM6TA CCCAGCCAGG GCCTT6M6T ACAMAACCT GCCCTTCAGA
CCTCAGTCCC CACArTATCT ACTG6TAMA GCCATCCST TCTGTAAGGA GGAGACCGTG CATGACAGT
TCATCATGCT GTTCTACACC AGGAGTCA66 ATGTGAGGAA GGCAGTGGAT 6AACACG CCC6CAT6
GATGCGCCCC AACCTGTCCA TCTCCTGCCC CTTCATGACA GAGCACACCA A6CCCATTAA CCACAGCA6G
GAGACCATA6 ATASMCCTC ABCBGCCTGC ACCBCAB6TA CTCA66CA6T GTGGGACATG GAGGAGAGAC
GAGTCA6UA GTGTGTGCCC AG6ACCTCAG ACTACAGGAG CATGATATT CAGGCABCCA ACCCTCCAA
CTTCTTGGGA rCw6T&muA CCTGTCT6CA mTTATCAG GTCTTCCCCA AGCAG6TGTo CATGASCTC
Pstl-
T6CA6ATAA CA6GGGCGTT BAATCCTCTT CCCATCTATG ATGA6TBT CAGCAGTTAT BTGAACGCCC
AGMGAGGC AGATBATATA AGCCATCATG A6GATGAGTC TGG66AGTAT GAGTCTGACT GC6AGtgatc
tgtactotgg acttggtatt aaagatgaac cctgttttgt aaaatatgta gatacataac taactaacta
actgtctgtq tatatattta attgagacct gagaccccca atcttaactc atgtcgaacc ctattAAATA
gatatatatt Gagcacttgt gtcttgtccc tctttgtctc tg
480
__.
B
0 797
El E2 E3
-t .t 0
560 825n 97n 122n
630 e: -
700 300n i tn 191n 1703n
770 1&%n
840
910 ie3: iin iin
980
1050
1120
1190
1260
1330
1400
1470
1540
1610
1680
1732
FIG. 2. Nucleotide sequence of exon 5 from 70 nt upstream of
the 5' end of the fifth exon to 31 nt downstream of the 3' end of the
ie3 transcript. The restriction enzyme sites AvaI (map unit 0.783),
XbaI (map unit 0.780), and PstI (map unit 0.776) are shown for
orientation. The polyadenylation signals and the 3' ends of the iel
and ie3 transcripts are indicated by capital letters and stars, respec-
tively. The fifth exon is underlined, and the coding sequence is
marked by capital letters.
residues may confer flexibility on the middle region of the
IE3 protein.
Comparison of the IE3 amino acid sequence with the
GenBank database (release 65, September 1990) by means of
the Genetics Computer Group sequence analysis software
package version 6.2 from June 1990 (11) detected significant
homology between the carboxy-terminal parts of the MCMV
IE3 amino acid sequence and the HCMV IE2 amino acid
sequence, which is encoded by reading frame UL 122 of
HCMV AD169 (5). An optimal alignment of the homologous
amino acid sequences is shown in Fig. 4. Eighty-five resi-
dues of the 200 carboxy-terminal amino acids are identical,
and a further 18 amino acids are replaced by conserved
residues. Two motifs (amino acids 416 to 425 and 527 to 536)
are nearly completely conserved between the two proteins.
Identification of the IE3 protein. To identify the ie3 gene
product(s), Western blot analysis with lysates of mock-
infected and MCMV-infected MEF in the IE phase was
performed (Fig. 5). The 1E3-specific antiserum directed
against the IE3 fusion protein, MAb 6/20/1, and antipeptide
serum b5/1 were employed in the Western blot analysis.
MAb 6/20/1 detects an epitope defined by amino acids 468
and 492 of the IE1 protein pp89 that is encoded by exon 4
sequences of the iellie3 gene complex and thus recognizes
only iel products (26). Antiserum bS/1 was raised against a
synthetic peptide from the common amino-terminal se-
0.783 0.773
1E3.END
IE3.1 E5
170tn
D
-
'111n
El E2 E3 . G A T C
0.85--
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FIG. 3. Structural analysis of the ie3 gene. Polymerase chain
reaction experiments were performed to analyze the exon intron
structure of the ie3 gene. (A) Top, restriction enzyme sites in the
iellie3 region: A, AvaI; D, DraI; P, PstI; X, XbaI; Xh, XhoI.
Bottom, positions of the primers employed in polymerase chain
reaction and sequence analysis. (B) Structure of the iel gene and
deduced structure of the ie3 gene. n, nucleotide. (C) Ethidium
bromide-stained agarose gel of amplified ie3 DNA fragments. ie3
mRNA was reverse transcribed by using primer E5, and parts of the
ie3 cDNA were amplified by using pnrmer pairs El-E5 (lane El),
E2-E5 (lane E2), and E3-E5 (lane E3). Amplified DNA fragments
were separated on 1.5% agarose gels. (D) Identification of the 3' end
of the ie3 mRNA. ie3 mRNA was reverse transcribed by using
primer (dT)17-Rl-RO, and the 3' part of the ie3 cDNA was amplified
by using the primers ie3.END and RO according to the protocol of
Frohman et al. (15). The noncoding strand of the amplified cDNA
fragment is shown. The arrow indicates the end of the ie3 mRNA.
quences of pp89 and the IE3 protein and should recognize
both proteins.
Western blot analysis of MCMV-infected cells in the IE
phase with the IE3-specific antiserum revealed an 88-kDa
protein, a 77-kDa protein of minor abundance, and a 54-kDa
protein (Fig. 5a, lane 2). These proteins could not be
detected in mock-infected cells (Fig. 5a, lane 1). MAb 6/20/1
recognizes only the iel products reported before, namely,
pp89, pp76, and two polypeptides with molecular masses of
67 and 51 kDa (Fig. Sb, lane 2). The antiserum against the
common amino terminus shows reactivity with proteins of 88
to 89 kDa in lysates of MCMV-infected cells (Fig. 5c, lane 2).
It was expected that this antiserum would detect both the
IEl and the IE3 proteins. As this antiserum did not reveal
the IE3 protein as a separate entity, it was unclear whether
p
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1 N E PAA P S C N M I M I AD Q A S V NAHG RH
26 L D E N R V Y P S D K V P A H V A N K I L E S G T
51 E T V R C D L T L E D M L G D Y E Y D D P T E E E
76 K I L M D R I A D H V G N D N S D N A I K H A A G
101 P E M N I D I V T A A A S N S G I T T A S H S A L
126 P I R R P N T P D F R R H S E K K A K K H K N K Q
151 R Q R L D D V V A K L H K P S E S E A D E D F I F
176 Q Q P Q E E E Y Q E E Q E P Q V I S S S P Q H F D
201 E R S P S R S S S D H G G H S G G N S R DG Q F Y
226 L SS G S E D E D D E D D E R V D S G Y R G S S R
251 S E D S S R Y R P H G G S H S S R S S I K S SG S
276 G S SRH H H K RKAV P E RHH P FT P P SAK
301 R Y A A A A P S S R Y E C P V R V D S S D S D D A
326 P TM V Q R G T L K I K S F R P P S S G S N S N K
351 H S S S S G G S T S S S H K K Q Q Q Q Q A P S K K
376 P VM S S G S D K I R D M V D R T A G G Y V A P N
401 A H K K C R E D K S R K Y P A R A L E Y K N L P F
R N T N - S
-
- - - - - - - 383
426 R PQ S P Q Y L L G K A I Q F C K E E T V H D K F
T IP - M H Q V - D E - - K A - - T M Q - N N - G 408
451 I M L F Y T R S Q D V R K A V D E T R A RN G N R
- Q1 I - - - N H I - K S E - - A V - C - L - T M 433
476 P NL S I S C P FN T E H T K P I N H S R E T I D
C - -A L - T - - L M - - - M - V T - P P - V A Q 458
501 R T S A A C T A G T Q A VW D N E E R RG Q K C V
- -A D - - N E - V K
-
A - S L K - L H T H Q L C 483
526 P RT S D Y R S M I I Q A A N P P D F LG A V K T
- -S - - - - N - - - H - - T - V - L - - - L N L 508
551 C L H L S Q V F P K Q V CN R L C S I T G G L N P
- -P - M - K - - - - - M V - I F - T N Q - G F M 533
576 L PI Y E E T V S S Y V N A Q F E A D D I S H H E
-
- - T AA K A - A V G- - - Q P T E T P P - 558
601 D ES 6 E Y E S D C E
- LD T L S L A I E A A I Q E L R N K S Q 579
FIG. 4. Deduced amino acid sequence of the MCMV IE3 protein
and alignment with the homologous part of the amino acid sequence
of the HCMV IE2 protein. The amino acid sequence of the MCMV
IE3 protein was deduced from the open reading frame of the ie3
mRNA. The amino-terminal sequence (amino acids 1 to 99; under-
lined) is shared between the IEl and IE3 proteins. The carboxy-
terminal part of the HCMV IE2 amino acid sequence was aligned
with the MCMV IE3 amino acid sequence. Identical amino acids are
indicated by dashes, and similar amino acids are underlined. Amino
acid positions of the MCMV IE3 and HCMV IE2 proteins are
numbered on the left and right, respectively.
the IE3 protein was of minor abundance and the IE3-specific
antiserum perhaps showed cross-reactivity only to the abun-
dantly expressed IEl protein or whether the IE3 protein is
almost identical in size to pp89. For clarification, the IEl and
IE3 proteins were expressed by vaccinia virus recombi-
nants. The vaccinia virus recombinant Vac-ie3 contains the
continuous ie3 open reading frame under control of the
vaccinia virus early-late promoter p7.5. The construction of
the vaccinia virus recombinant Vac-iel, which contains the
iel open reading frame, has already been reported (50).
Western blot analysis of lysates from Vac-ie3-infected
cells (Fig. Sa, lane 4) with the IE3-specific antiserum re-
vealed mainly the same 88-kDa protein as in lysates of
MCMV-infected cells and, weakly, the 77-kDa protein.
Reactivity with the 54-kDa protein, however, was of back-
ground level, also seen in lysates of wild-type vaccinia virus(wt-Vac)-infected cells (Fig. 5a, compare lane 2 with lanes 3
to 5). The variable reaction of the IE3-specific antiserum
with a 62-kDa protein (Fig. 5a, lane 5) was also observed in
lysates of wt-Vac- and Vac-ie3-infected cells and was there-
MCMV VAC
m le wt le3 lel
88- 1 m
kDa a
MCMV VAC
m le wt ie3 lel
MCMV VAC
m iewt le3 iel
a1 m a ~ oo-89
4W
b
FIG. 5. Detection of the MCMV IE3 protein by Western blot
analysis. Protein lysates of mock-infected cells (lane 1), MCMV-
infected cells arrested in the IE phase (lane 2), and cells infected
with wt-Vac (lane 3), Vac-ie3 (lane 4), and Vac-iel (lane 5) were
reacted with IE3-specific antiserum (a), IEl-specific MAb 6/20/1 (b),
and IE1-IE3-specific antipeptide serum directed against amino-
terminal sequences (c).
fore considered unspecific. Thus, cross-reactivity of the
IE3-specific antiserum with the abundantly expressed IEl
protein pp89 could be excluded. In lysates of Vac-iel-
infected cells, MAb 6/20/1 detected the IEl protein pp89
(Fig. 5b, lane 5) but not the ie3 product expressed in
Vac-ie3-infected cells (Fig. Sb, lane 4). pp76 and the S1-kDa
polypeptide, which are detected by MAb 6/20/1 in Vac-iel-
infected cells as well as in MCMV-infected cells (Fig. Sb,
lanes 2 and 5), represent processing products of pp89 (23,
24). In lysates of Vac-ie3- and Vac-iel-infected cells, the
antiserum against the amino terminus detects, as expected,
an 88- and an 89-kDa protein, respectively (Fig. Sc, lanes 4
and 5).
These results suggest that the identified ie3 open reading
frame encodes an 88-kDa protein. The reactivity of the
antiserum against the amino terminus with an 88- and an
89-kDa protein in lysates of Vac-ie3- and Vac-iel-infected
cells, respectively, confirms that the IE3 protein and pp89
share amino-terminal residues. The almost-identical migra-
tional properties of pp89 and the 88-kDa IE3 protein explain
why the ie3 product had previously escaped detection.
Expression kinetics of the IE3 protein. To study the expres-
sion kinetics of the IE3 protein, lysates of MCMV-infected
MEF were prepared at different times after infection, and
Western blot analysis was performed with the IE3-specific
antiserum (Fig. 6a) and the IEl-specific MAb 6/20/1 (Fig.
6b). Overexpression of IE proteins was achieved by arrest-
ing the MCMV-infected cells in the IE phase as described in
Materials and Methods. The 88-kDa IE3 protein was first
detected at 2 h p.i. During the early phase, which lasts from
2 to 16 h p.i., a stepwise shift of the 88-kDa band toward an
89- and a 90-kDa band was observed, which suggested
posttranslational modification. Although a smaller amount of
protein was loaded in lanes representing values for 16 and 24
h p.i., it is clear that the 89- and 90-kDa ie3 products are also
present during the late phase of the replication cycle. A faint
band corresponding to pp89 was already detectable at 1 h p.i.
The presence of pp89 during the whole replication cycle has
been reported before (24), and the gel migration properties
are constant. Altogether, the data show that the IE3 protein
and pp89 have comparable expression kinetics.
IE3 protein is sufficient for trans activation of the MCMV
early promoter el. The characterization of the MCMV early
transcription unit el (3) allowed us to analyze whetherTEl or
IE3 or both are necessary for the activation of the el
promoter. To perform transient transfection experiments, a
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FIG. 8. Regulation of the MCMV iellie3 promoter by IE pro-
teins. The indicator plasmid pIElCAT was transfected into MEF
alone (lanes 1) or in combination with the effector plasmids pAMB33
(lanes 2), pIElll (lanes 3), pIE100/1 (lanes 4), pIE3 (lanes 5), and
pIE3 plus pIE100/1 (lanes 6). CAT activities were determined as
described in Materials and Methods.
89- . 4
kDa b
FIG. 6. Western blot analysis of IE3 protein expression kinetics.
Lysates of mock-infected MEF (lane m), MCMV-infected MEF in
the IE phase (lane ie), and MCMV-infected MEF at various hours
p.i. (hours are given above each lane) were reacted with IE3-specific
antiserum (a) and IEl-specific MAb 6/20/1 (b).
plasmid containing the indicator gene CAT under the control
of the el promoter was constructed. Different effector plas-
mids were used for the expression of the TEl and IE3
proteins (Fig. 1). The plasmid pIE111, which encompasses
the MCMV IE region, encodes the complete iellie3 gene
complex (13, 22, 23). The plasmid pIE100/1 encodes only
IE1 proteins, as sequences downstream of the fourth exon at
map unit 0.783 (Aval) are not included. The plasmid pIE3
differs from pIE111 by the deletion of the third intron and the
fourth exon and thus encodes only the IE3 protein.
MEF, which are permissive for MCMV infection, were
used for transfection experiments. Transfection of the indi-
cator plasmid pElCAT alone resulted in a low basal level of
CAT activity (Fig. 7, lanes 1). Following cotransfection of
pElCAT and pIE111, a 200-fold induction of CAT activity
was observed (Fig. 7, lanes 2), demonstrating that IE pro-
teins encoded by pIE111 activate the early promoter el.
After cotransfection of pElCAT and pIE100/1, only a low
level of CAT activity was detected, indicating that the early
promoter was not activated by the iel gene product alone
(Fig. 7, lanes 3). In contrast, cotransfection of pElCAT and
1 2 3 4 5
.*.
FIG. 7. Activation of the MCMV el promoter by IE proteins.
Transfection experiments in MEF were performed in duplicate with
the indicator plasmid pElCAT alone (lanes 1) or in combination with
the effector plasmids pIE111 (lanes 2), pIE100/1 (lanes 3), pIE3
(lanes 4), and pIE3 plus pIE100/1 (lanes 5). Cell extracts were
prepared 40 h after transfection and assayed for CAT activity.
pIE3 resulted in a 150-fold induction ofCAT activity (Fig. 7,
lanes 4). Therefore, the IE3 protein is sufficient for trans
activation of the el promoter, whereas the IEl protein is not.
To study a potential cooperation between the IEl and IE3
proteins in the activation of the early promoter, pElCAT
and the two effector plasmids pIE100/1 and pIE3 were
cotransfected. The observed CAT activity was 1.5 to 2 times
higher than after transfection of pElCAT and pIE3 (Fig. 7,
lanes 5). This suggests that the IE1 protein has some additive
effect on the trans-activating properties of the IE3 protein.
Repression of the iellie3 promoter by the IE3 protein.
Transcription of the MCMV IE genes ceases during the early
phase of infection (21, 24). A possible mechanism for this
downregulation is an autoregulatory repression of the
MCMV IE promoters by the IE proteins. To study the
regulation of the iellie3 promoter, an indicator plasmid
containing the CAT gene under the control of the iellie3
promoter and upstream enhancer sequences was con-
structed. Because the upstream sequences in all effector
plasmids are identical to those in the indicator plasmid, the
plasmid pAMB33 (23) was included as a control for compe-
tition for cellular transcription factors. pAMB33 contains a
2.25-kbp PstI fragment (map units 0.806 to 0.796) encom-
passing the enhancer and the iellie3 promoter (Fig. 1).
Transfection of the indicator plasmid pIElCAT into MEF
resulted in high CAT activity (Fig. 8, lanes 1) due to the
MCMV enhancer activity (13, 25). Following transfection of
pIElCAT and pAMB33, a reduction of CAT activity by 25%
could be seen (Fig. 8, lanes 2), indicating a slight competition
for transcription factors. Cotransfection of pIElCAT and
pIE111, however, resulted in a fivefold repression of the
iellie3 promoter (Fig. 8, lanes 3), whereas no suppression or
even some activation was seen after cotransfection of
pIElCAT and pIE100/1 (Fig. 8, lanes 4). This indicated that
the IEl protein alone has no major effect on the iellie3
promoter, whereas the expression of the complete iellie3
gene complex resulted in repression. To study whether the
repression of the iellie3 promoter is a function of the IE3
protein alone, cotransfection of pIElCAT and pIE3 was
carried out. The strong reduction of CAT expression (Fig. 8,
lanes 5) confirmed that the iellie3 promoter is negatively
regulated by the IE3 protein. Cotransfection of pIElCAT,
pIE3, and pIE100/1 resulted in the same reduced CAT
activity as that resulting from transfection of pIElCAT and
pIE3 (Fig. 8, lanes 6), indicating that under the experimental
conditions applied, the repressive properties of the IE3
protein prevented a potential activation of the iellie3 pro-
moter by the IE1 protein.
VOL. 66, 1992
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DISCUSSION
In this communication, we report on (i) the structure of the
ie3 gene of the MCMV iellie3 gene complex; (ii) the expres-
sion of the ie3 product, an 88-kDa protein; and (iii) the
function of this protein in positive and negative transcrip-
tional regulation of homologous promoters. The data show
that in contrast to the TEl and IE2 proteins of MCMV
described by us previously (22, 35), the IE3 protein shows a
striking homology to its HCMV counterpart, the HCMV IE2
protein, in its amino acid sequence and a great similarity in
regulatory function. Similar to the function of the HCMV
IE2 protein in HCMV, the MCMV IE3 protein is probably
the major transcriptional regulator for the initiation of early
gene expression in MCMV. The availability of both genes
will allow a direct and more-detailed comparison of their
functions and thus aid the understanding of these important
regulatory proteins of CMV.
The MCMV iellie3 gene complex comprises five exons.
Differential splicing leads to the 2.75-kb iel and ie3 tran-
scripts. Splicing from the first or second exon to the fifth
exon was not observed. Therefore, two major IE transcripts
originate from the MCMV iellie3 gene complex: the iel
mRNA, which is composed of exons 1, 2, 3, and 4, and the
ie3 mRNA, consisting of exons 1, 2, 3, and 5. These aspects
of the structural organization of the MCMV IE region are
identical to those of the HCMV IE region, which is also
composed of five exons (18, 43, 45, 46). In HCMV, distinct
minor mRNA species originating from exon 5 sequences
have been identified (43, 46). It has been proven that a
splicing event resulting in a transcript which encodes a
55-kDa HCMV IE2 protein can occur within the fifth exon.
We were not able to detect distinct minor IE mRNA species
in MCMV, although a smear of smaller mRNAs is indicative
of their existence (23). S1 nuclease analysis with various
end-labeled DNA fragments from the ie3 region revealed no
RNA species that are generated by a splicing event within
exon 5. If potential shorter transcripts from the MCMV ie3
region have escaped detection, they must be of low abun-
dance. Further cDNA cloning experiments are needed to
clarify the origin of the smaller IE transcripts.
The open reading frame of the ie3 transcript predicted a
polypeptide of 611 amino acids with a calculated molecular
mass of 68 kDa. An 88-kDa protein was identified as the
major ie3 gene product. Integration of the identified ie3 open
reading frame into vaccinia virus and expression of an
88-kDa protein in Vac-ie3-infected cells confirmed that the
88-kDa IE3 protein is encoded by the 2.75-kb ie3 mRNA.
The low-abundance 77-kDa protein probably represents a
modification product of the 88-kDa protein, as the 77-kDa
protein is also detected in lysates of Vac-ie3-infected cells.
The IE3-specific antiserum reacted with a 54-kDa protein
after enhanced expression of IE proteins by MCMV but not
after infection with the splicing-incompetent vaccinia virus
recombinant. The possibility that this protein is translated
from a differentially spliced transcript is therefore not ex-
cluded, and further studies are required to clarify whether it
represents the homolog of the HCMV 55-kDa IE2 protein.
The 88-kDa IE3 protein shows a slower mobility in SDS-
polyacrylamide gels than expected from the calculated mo-
lecular mass of the deduced amino acid sequence, an obser-
vation also characteristic for the MCMV IE1 protein and the
HCMV IE proteins (22, 24, 43-45). During the early phase of
the MCMV replication cycle, the molecular mass of the IE3
protein shifted to 89 and 90 kDa, suggesting posttranslational
modification. Large serine clusters are located within the
amino acid sequence of IE3, and the increase of the molec-
ular mass could be due to phosphorylation. The IE3 protein
was detected throughout the replication cycle and had
expression kinetics similar to those of the IEl protein pp89,
suggesting a functional role of the IE3 protein during the
whole replication cycle.
A series of structural domains within the amino acid
sequences of cellular transcription factors and viral regula-
tory proteins which are responsible for DNA binding, dimer-
ization, and transcriptional activation have been character-
ized (27, 36). A structure involved in DNA binding, the
so-called "zinc finger" motif (27, 36), was found within the
HCMV IE2 amino acid sequence (30, 44). However, no zinc
finger was identified within the amino acid sequence of
MCMV IE3. Another motif, the "leucine zipper," mediates
dimerization of transcriptional active proteins. Basic amino
acids, which are usually located adjacent to the leucine
zipper motif, are responsible for the DNA binding of leucine
zipper proteins. Several leucine-rich regions were identified
in the HCMV IE2 sequence (30, 44). Again, no such struc-
tures were found in the amino acid sequence of MCMV IE3.
Transcriptional activator domains of yeast activator pro-
teins and of the herpes simplex virus regulatory protein
Vmw65 are characterized by acidic residues (47, 49). Fur-
thermore, serine/threonine-, glutamine-, and proline-rich do-
mains have been implicated in transcriptional activation by
regulatory proteins (9, 34). IE3 has three short acidic clus-
ters (amino acids 166 to 177, 180 to 188, and 231 to 239) and
a series of five glutamine residues (amino acids 365 to 370).
In addition, 10 of the 20 carboxy-terminal amino acids of the
IE3 protein are acidic. The short acidic clusters have coun-
terparts in the amino acid sequence of the HCMV IE2
protein, although the precise locations are not conserved
(43). The 29 carboxy-terminal amino acids of the HCMV IE2
protein include 7 acidic residues, and they may fold into an
amphipathic alpha helix (30). The precise positions of these
negatively charged residues are not conserved in the amino
acid sequence of MCMV IE3, and the propensity of the
carboxy terminus of MCMV IE3 to form an amphipathic
alpha helix is low. Altogether, the 200 carboxy-terminal
amino acids of MCMV IE3 and HCMV IE2 represent the
region of major homology, which suggests an important
function for this domain of the CMV IE proteins.
Transfection experiments in MEF, which are permissive
for MCMV infection, were performed with indicator genes
under the control of the homologous early promoter el or the
iellie3 promoter and effector plasmids encoding the different
MCMV IE proteins. Characterization of the MCMV early
transcription unit el (3) and structural analysis of the MCMV
iellie3 gene complex allowed us to analyze in detail which IE
proteins are required for the activation of the homologous
early promoter el. The IE3 protein alone was found to be
sufficient for the activation of the el promoter, whereas the
IEl protein alone was not, but IEl could act synergistically
with the IE3 protein. Therefore, the IE3 protein apparently
represents the major IE regulatory protein for the activation
of early genes in permissive cells. Because we have shown
previously that the IEl protein can activate heterologous
promoters (25, 39), the IE1 protein may still possess a
function in the activation of cellular genes.
In its requirement for IE proteins for trans activation, the
MCMV el promoter shows similarity to some HCMV early
promoters. An HCMV E transcription unit corresponding to
the MCMV transcription unit el is located between map
units 0.682 and 0.713 of the HCMV genome (3, 42). The
promoter of this HCMV early gene can be activated by
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HCMV IEl and IE2 proteins (41). Similar to the induction of
the MCMV el promoter by the MCMV IE3 protein, the
HCMV IE2 protein alone can also activate the HCMV E1.7
promoter (4). The activation of this HCMV promoter by
HCMV IE2 is also augmented by the HCMV IE1 protein
(30).
The autoregulative effect of the MCMV IE3 protein on the
iellie3 promoter may explain the reduction of IE transcrip-
tion at the beginning of the early phase (21, 24). Similar to
the way the MCMV IE3 protein represses the MCMV iellie3
promoter, the HCMV IE2 protein downregulates the tran-
scription of genes under the control of the HCMV major IE
promoter (6, 17, 28, 37, 38, 44). The target sequences
mediating repression of the HCMV major IE promoter by
the HCMV IE2 protein have been defined and are conserved
between HCMV and SCMV (6, 17, 28, 37) but do not exist in
the MCMV iellie3 promoter and cannot be replaced by
MCMV sequence motifs, since the HCMV IE2 protein
cannot repress transcription from the MCMV iellie3 pro-
moter (17). Thus, the MCMV IE3 protein mediates repres-
sion of the iellie3 promoter by different and as-yet-undefined
target sequences.
Mutational analysis of domains which are conserved be-
tween the different CMV homologs will show which domains
are important for the functions of the MCMV IE3 protein
and will help us understand the control of transcriptional
regulation in CMV.
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